Intranasal Oligonucleotide Delivery: Nanopharm & Aptar Pharma Data

Nanopharm and Aptar Pharma present new data at IPAC-RS NIF 2026 proving Antisense Oligonucleotide (ASO) biologics can be nasally delivered intact

Why it is time to ‘Think Different’ about nasal delivery of biologics.

Nanopharm discusses the challenges and benefits of delivering biologics via the nasal route.

Nanopharm’s Innovations in Nasal Drug Delivery of Biologics

Discover Nanopharm’s pioneering work in nasal drug delivery of biologics. Learn how their research is shaping drug development against SARS-CoV-2.